These policy proposals come at a cost and introduce risks to benefit design, pharmacies, and providers in ways that may compromise patient access and delivery of care
GLP-1 (glukagonu podoben peptid-1) je hormon, ki se naravno proizvaja v revesju in ima kljuno vlogo pri nadzoru apetita, signalizaciji inzulina in ravnovesju sladkorja v krvi
DXA data from the STEP-1 and SURMOUNT-1 trials show meaningful lean mass reduction during GLP-1-driven weight loss: approximately 9.7% of total lean tissue with semaglutide in STEP-1, and 10.9% with tirzepatide in SURMOUNT-1
While these treatments help reduce appetite and support metabolic health, aging bodies require special care-especially when it comes to protecting bones and muscles
Nicotinamide phosphoribosyltransferase is required for the calorie restriction-mediated improvements in oxidative stress, mitochondrial biogenesis, and metabolic adaptation
it is the only way to safeguard biology, prevent sarcopenia, and deliver long-term outcomes
